title: Challenges of creating effective chimeric antigen receptors for cancer therapy.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Sentman
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000639:trends; D058990:Molecular Targeted Therapy; D015202:Protein Engineering; D011946:Receptors, Antigen / Q000276:immunology*; D055607:Receptors, Natural Killer Cell / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology*; D015398:Signal Transduction
chemical_list: D015703:Antigens, CD; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D011946:Receptors, Antigen; D055607:Receptors, Natural Killer Cell; D011993:Recombinant Fusion Proteins
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17481-6
references.pmid: 18987320
references.citation: Blood. 2011 Aug 4;118(5):1255-63
references.pmid: 21653320
references.citation: J Immunol. 2012 Jun 15;188(12):6389-98
references.pmid: 22586039
references.citation: Hum Gene Ther. 2011 Dec;22(12):1575-86
references.pmid: 21838572
references.citation: Sci Transl Med. 2013 Mar 20;5(177):177ra38
references.pmid: 23515080
references.citation: Mol Ther. 2010 Apr;18(4):843-51
references.pmid: 20179677
references.citation: Blood. 2012 May 3;119(18):4133-41
references.pmid: 22354001
references.citation: Nat Biotechnol. 2013 Jan;31(1):71-5
references.pmid: 23242161
references.citation: N Engl J Med. 2011 Nov 3;365(18):1673-83
references.pmid: 22047558
references.citation: J Clin Invest. 2011 May;121(5):1822-6
references.pmid: 21540550
references.citation: J Immunother. 2013 Feb;36(2):133-51
references.pmid: 23377668
references.citation: Cancer Discov. 2013 Apr;3(4):388-98
references.pmid: 23550147
references.citation: Sci Transl Med. 2011 Aug 10;3(95):95ra73
references.pmid: 21832238
references.citation: J Immunol. 2008 Jan 1;180(1):72-8
references.pmid: 18097006
references.citation: Cancer Res. 2007 Nov 15;67(22):11029-36
references.pmid: 18006849
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3360-5
references.pmid: 19211796
references.citation: Cancer Res. 2013 Mar 15;73(6):1777-86
references.pmid: 23302231
references.citation: Immunol Cell Biol. 2013 Jul;91(6):435-40
references.pmid: 23628805
references.citation: Trends Biotechnol. 2011 Nov;29(11):550-7
references.pmid: 21663987